Author: Lochner C. Hemmings S.M.J. Kinnear C.J. Moolman-Smook J.C. Corfield V.A. Knowles J.A. Niehaus D.J.H. Stein D.J.
Publisher: Elsevier
ISSN: 0924-977X
Source: European Neuropsychopharmacology, Vol.14, Iss.2, 2004-03, pp. : 105-113
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Advances in the pharmacotherapy of obsessive-compulsive disorder
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :
Pathogenetic mechanism of obsessive-compulsive disorder
By Kafka J. Paacute lovaacute E.
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :
Animal Models for Obsessive-Compulsive Disorder
Current Neuropharmacology, Vol. 2, Iss. 2, 2004-04 ,pp. :
Treating obsessive-compulsive disorder with serotonin reuptake inhibitors
By Koran L.M.
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :